ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0736

Decrease in Prevalence of Self-Reported Anxiety or Depression in Persons with Osteoarthritis After Total Knee Arthroplasty: The BEST KNEE Cohort Study

Owen Krystia, Lauren King, Esther Waugh and Gillian Hawker, University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2021

Keywords: Anxiety, depression, Osteoarthritis, Total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Osteoarthritis – Clinical Poster II (0723–0738)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: While anxiety and depression are highly prevalent in persons with symptomatic knee osteoarthritis (OA), few studies have assessed the effect of treatment of knee OA on these mood disorders. Further, it remains unclear which individuals will continue to have persistent anxiety and/or depression after OA treatment, limiting targeted intervention. Thus, the objectives of this study were to, in individuals with knee OA undergoing primary total knee arthroplasty (TKA): (1) describe the proportion of patients who report being anxious or depressed (A/D) pre TKA, 6 months post TKA, and 12 months post TKA; and (2) determine, in those with self-reported A/D pre TKA, the factors associated with persistence of mood disorder at 12 months post TKA.

Methods: In this prospective cohort study, patients with knee OA were assessed one month pre- and 6 and 12 months post-TKA. Questionnaires assessed sociodemographic factors, knee OA symptoms, comorbidities, and psychosocial factors. We assessed prevalence of self-reported A/D using the Anxiety/Depression dimension of the EQ-5D-3L. Self-reported A/D was defined as reporting being moderately or extremely anxious or depressed. Among individuals with self-reported A/D pre TKA, multivariable Poisson regression with a robust error variance was used to assess the association of sociodemographic factors, comorbidities, psychosocial factors, and knee OA symptoms with persistence of self-reported A/D at 12 months post TKA.

Results: 1259 patients were included: mean age 67.2 years, 60.8% female, mean pre TKA WOMAC pain 57.6 (SD 17.4) /100, and mean pre TKA KOOS-PS physical function 53.3 (SD 17.3)/100 (higher scores worse). The mean change from pre TKA to 12 months post TKA in WOMAC pain was -42.7 (SD 21.9), and in KOOS-PS was -29.6 (SD 21.5). Prevalence of self-reported A/D pre TKA was 624 (49.6%), at 6 months was 278 (22.1%), and at 12 months was 254 (20.2%). Of the 624 participants with self-reported A/D pre TKA, 197 (31.6%) self-reported A/D 12 months post TKA. In multivariable regression, persistence of A/D at 12 months post TKA was associated with reporting higher levels of knee OA pain post TKA (RR per WOMAC unit 1.02, 95% CI 1.01 to 1.03), greater knee OA functional impairment post TKA (RR per KOOS-PS unit 1.01, 95% CI 1.00 to 1.03), less pre TKA self-efficacy (RR per unit General Self-Efficacy Scale 0.97, 95% CI 0.94 to 0.99), and the presence of a pre TKA depression diagnosis (RR 1.89, 95% CI 1.44 to 2.48). Analyses stratified by sex, age (< 60/≥60 years), obesity, and reporting a prior diagnosis of depression were not appreciably different from the primary model.

Conclusion: A large proportion of individuals with knee OA report being anxious or depressed pre TKA. Of these individuals, greater than two-thirds report resolution of their mood disorder by 12 months post TKA. We found a higher risk of persistence in individuals with worse knee OA symptoms post TKA and among those with less self-efficacy. However, the strongest factor associated with persistence of A/D was a previous diagnosis of depression suggesting a group of individuals whose depression may not be related to their OA and would benefit from targeted mental health interventions to improve mood outcomes.


Disclosures: O. Krystia, None; L. King, None; E. Waugh, None; G. Hawker, None.

To cite this abstract in AMA style:

Krystia O, King L, Waugh E, Hawker G. Decrease in Prevalence of Self-Reported Anxiety or Depression in Persons with Osteoarthritis After Total Knee Arthroplasty: The BEST KNEE Cohort Study [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/decrease-in-prevalence-of-self-reported-anxiety-or-depression-in-persons-with-osteoarthritis-after-total-knee-arthroplasty-the-best-knee-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/decrease-in-prevalence-of-self-reported-anxiety-or-depression-in-persons-with-osteoarthritis-after-total-knee-arthroplasty-the-best-knee-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology